EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Sky Century Investment, Inc (SKYI) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of Sky Century Investment, Inc $0.04, price $0.07, upside -46.7%, quality 44 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Healthcare · US · ISIN US83084W1045

SC Sky Century Investment, Inc logo Thin data Oct 3, 2026

Sky Century Investment, Inc

SKYI · US

Weakest SetupStrongly overvalued and low quality.

Quality 44/100
Mixed Growth (revenue 5y +10.5 %/yr in USD)
Negative equity (buybacks among others)
Fair value $0.0359 · Strongly overvalued (−46.7%)
Loss-making · -49.7% net margin (TTM)
Negative free cash flow
Trails peers (1/7)
Narrow moat 5/100
Thin data
⚠ Dilution
Watch Sky Century Investment, Inc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$41.00 $0.0521 Fair Value $0.0359 Jul 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.

How to read this chart

60‑month range $0.0521 – $41.00 · fair‑value band $0.0302 – $0.0416 · the $0.0674 price screens above the $0.0359 fair value. Dashed = 300-day average. As of Oct 3, 2026.

Follow Sky Century Investment in your weekly email

Every Wednesday you see whether Sky Century Investment is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Sky Century Investment, Inc. provides IT and marketing services, and RSS feeds and podcasts. The company offers technical support services, including maintenance, troubleshooting, and system upgrades; and leased high-performance servers that enables them to scale operations without significant upfront capital investment.

Show more

Sky Century Investment, Inc. provides IT and marketing services, and RSS feeds and podcasts. The company offers technical support services, including maintenance, troubleshooting, and system upgrades; and leased high-performance servers that enables them to scale operations without significant upfront capital investment. It also sells RSS feeds of cannabis news to news organizations, websites, and other businesses; and Cannabis News, a mobile application designed for cannabis-related information. In addition, the company provides marketing services, including digital marketing, branding, and market research. Sky Century Investment, Inc. was incorporated in 2012 and is based in Las Vegas, Nevada.

Stock analysis

Sky Century Investment, Inc (SKYI) currently trades at $0.0674, while our model-based Fair Value estimate is $0.0359, 46.7% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the evidence level at low.

Scenario range: $0.0302 (bear) to $0.0416 (bull), the price of $0.0674 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 44/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Sky Century Investment, Inc reported revenue of $126K in FY2026 versus $61.0K in FY2022, a compound +19.9%/yr. Reported net income was −$62.5K in FY2026.

Key figures

Market cap $468K · P/S ratio 3.71 · EPS (TTM) $−0.0100 · Net margin −49.5% · Return on assets (EBIT) −136% · Operating margin −11.3% · Revenue (TTM) $126K · Revenue growth (YoY) +24.3%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 26 out of 100 (low confidence).

What moves the price

The share trades about 97% below its 52-week high and 29% above its 52-week low.

For context, the median of 10 Healthcare peers we cover trades at −19% fair-value upside, at −47%, SKYI screens richer than that median.

Fair Value models

Bear $0.0302 Fair Value $0.0359 Bull $0.0416
Price $0.0674 · Upside -46.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
EV/EBITDA $0.0200 $0.0300 $0.0400 63
All 1 models by family
Multiples
EV/EBITDA $0.0200 $0.0300 $0.0400 63

Open the full fair value analysis →

Notify me when SKYI reaches fair value

Put SKYI on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 44/100

Of which business quality 44 · Market factors (momentum, volatility) 2

Profitability 42
Margins and returns on capital today
Quality Growth 100
Are margins and returns improving?
Cashflow 50
Earnings quality: real cash, not paper profit
Fin. Strength 0
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 0
Calm price path (market factor)
Momentum 4
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 0
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 22/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+65.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.5%
Start year 2021 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+23.3%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−6.9% (2021) → −49.5% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed

SKYI screens overvalued: fair value 47% below the price. Compare with Merck KGaA →

Compare Sky Century Investment, Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 600 stocks

Beats the industry median on 1/7 measures
Overall it trails its industry peers.
Valuation
Quality Score 44 · Below median
Fair Value upside −46.7% · Below median
Profitability
Return on equity (TTM) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets −31.0% · Bottom 25%
Net margin (TTM) −49.7% · Bottom 25%
Operating margin (TTM) −11.3% · Bottom 25%
Growth and dividend
Revenue growth 24.3% · Top 25%
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (TTM) 3.71× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 17
FUTURE (revenue growth)100 · sector 24
PAST (return on equity)0 · sector 26
HEALTH (low debt)0 · sector 96
DIVIDEND (yield)0 · sector 31

VALUE 0: the price sits above our fair-value range.

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Merck KGaA MRK €134.45 €108.94 −19%
Takeda Pharmaceutical Company TAK $17.86 $11.35 −36%
Teva Pharmaceutical Industries Limited TEVA $39.31 $20.88 −47%
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,852 ₹1,979 +7%
Galderma Group GALD CHF 163.00 CHF 110.32 −32%
Jiangsu Hengrui Pharmaceuticals Co 600276 ¥44.86 ¥49.35 +10%
Haleon plc HLN $9.26 $8.49 −8%
Sandoz Group SDZ CHF 71.16 CHF 40.32 −43%
Zoetis Inc ZTS $69.69 $110.50 +59%
Divi's Laboratories Limited DIVISLAB ₹9,620 ₹1,871 −81%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Sky Century Investment, Inc · Fair Value
$0.0359 −47%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Sky Century Investment, Inc Fair Value". https://www.fairvalue-calculator.com/stock/SKYI

Frequently asked questions

Is Sky Century Investment, Inc (SKYI) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of $0.0359 versus a price of $0.0674, about −47% upside (overvalued).
What is the fair value of SKYI?
Our model-based fair value for Sky Century Investment, Inc is $0.0359 (as of Oct 3, 2026), built from audited fundamentals. The current price: $0.0674.
What is the quality score of SKYI?
Sky Century Investment, Inc has a Quality Score of 44/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Sky Century Investment, Inc (SKYI)?
Our model-based price target is the fair value of $0.0359 (as of Oct 3, 2026) from 1 valuation models. Cautious scenario $0.0302, optimistic scenario $0.0416. It is a calculation from audited fundamentals, not an analyst target.
What is the Sky Century Investment, Inc stock forecast for 2026?
Our models put fair value at $0.0359, about −47% upside versus a price of $0.0674 (overvalued). Cautious scenario $0.0302, optimistic scenario $0.0416. The calculation is refreshed regularly with new filings.
What is the revenue of Sky Century Investment, Inc (SKYI)?
Sky Century Investment, Inc reported trailing-twelve-month revenue of about $126K (latest available figure, as of Oct 3, 2026).
What is the intrinsic value of Sky Century Investment, Inc (SKYI)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Sky Century Investment, Inc it is $0.0359 per share (as of Oct 3, 2026), against a price of $0.0674. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Sky Century Investment, Inc stock overvalued or undervalued in 2026?
As of Oct 3, 2026, SKYI trades above its calculated fair value: price $0.0674, fair value $0.0359, a gap of about −47% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SKYI?
No. The price is what the market pays today ($0.0674); the fair value is what the company's own numbers justify ($0.0359). For Sky Century Investment, Inc the two are $0.0315 per share apart. That gap is exactly why we show both numbers side by side.
How much is Sky Century Investment, Inc worth?
The market values Sky Century Investment, Inc at about $468K (market capitalisation, as of Oct 3, 2026). Per share that is $0.0674; our models calculate a fair value of $0.0359 per share.
What do the bullish and bearish scenarios say about SKYI?
Our models span a range for Sky Century Investment, Inc: cautious scenario $0.0302, base $0.0359, optimistic $0.0416 per share (as of Oct 3, 2026, price $0.0674). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Sky Century Investment, Inc (SKYI)?
Balance-sheet figures for Sky Century Investment, Inc (as of Oct 3, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 44/100, which measures business quality independently of the share price.
How far is SKYI from its 52-week high?
Sky Century Investment, Inc trades at $0.0674, about 97% below its 52-week high of $1.99 and 29% above the low of $0.0521 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0359 is for.
Which stocks are comparable to Sky Century Investment, Inc?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Sky Century Investment, Inc stock attractive at the current price?
The data as of Oct 3, 2026: price $0.0674, calculated fair value $0.0359 (−47%), Quality Score 44/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SKYI calculated?
We run Sky Century Investment, Inc through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0359, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.0 % above its aggregate fair value. Sky Century Investment, Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Sky Century Investment, Inc (SKYI)?
The closing price on Oct 2, 2026 was $0.0674. Our model-based fair value is $0.0359, about −47% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Sky Century Investment, Inc right now?
The price sits above even our optimistic bull case ($0.0416). The favourable scenario is already priced in. Weak quality (44/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Sky Century Investment, Inc

How large is the market capitalisation of Sky Century Investment, Inc (SKYI)?
The market capitalisation of Sky Century Investment, Inc is $468K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Sky Century Investment, Inc (SKYI)?
The price-to-sales ratio of Sky Century Investment, Inc is 3.71 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Sky Century Investment, Inc (SKYI)?
Earnings per share at Sky Century Investment, Inc are $−0.0100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Sky Century Investment, Inc (SKYI)?
The net margin of Sky Century Investment, Inc is −49.5% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Sky Century Investment, Inc (SKYI)?
On an EBIT basis the return on assets of Sky Century Investment, Inc is −136% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Sky Century Investment, Inc (SKYI)?
The operating margin of Sky Century Investment, Inc is −11.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Sky Century Investment, Inc (SKYI)?
Revenue at Sky Century Investment, Inc is growing +24.3% versus a year earlier (3y avg +19.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Sky Century Investment, Inc (SKYI) generate?
The free cash flow of Sky Century Investment, Inc is −$129K (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Sky Century Investment, Inc (SKYI) hold?
Sky Century Investment, Inc holds more cash than debt, $264 net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Sky Century Investment, Inc in the live analysis

One click puts Sky Century Investment, Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.